Short interest in Recursion Pharmaceuticals Inc (NASDAQ:RXRX) increased during the last reporting period, rising from 168.52M to 174.14M. This put 35.44% of the company's publicly available shares ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

The Kill Chain models how an attack succeeds. The Attack Helix models how the offensive baseline improves. Tipping Points One person. Two AI subscriptions. Ten government agencies. 150 gigabytes of ...

Access detailed historical stock prices, including daily closing prices, for RXRX. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...

Faculty members at Northeast Community College are beginning to integrate artificial intelligence tools into their classrooms ...

过去一两年，ChatGPT 等 AI 聊天工具凭借强大信息处理能力，成为工作中的 “万能顾问”，高效搞定写邮件、解疑问等需求。但面对业务执行场景，它们暴露短板：仅能提供方案，缺乏行动力、无法集成内部系统、难串联复杂流程，始终是 ...

Major release delivers seamless Ignition SCADA, enterprise-grade security, advanced ML algorithms, and private cloud ...